{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:25:12Z","timestamp":1787275512404,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Program","award":["2019KY648"],"award-info":[{"award-number":["2019KY648"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05846-0","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:16:12Z","timestamp":1787274972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atractylenolide I alleviates LPS-induced pulmonary cell injury relevant to pediatric pneumonia via the ERK\/USP9X\/Mcl-1 and Akt\/Survivin axes"],"prefix":"10.1007","author":[{"given":"Jinglei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peini","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"5846_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1486072","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S et al (2025a) Atractylenolide-I prevents abdominal aortic aneurysm formation through inhibiting inflammation. Front Immunol 16:1486072","journal-title":"Front Immunol"},{"key":"5846_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157564","volume":"149","author":"L Chen","year":"2025","unstructured":"Chen L et al (2025b) Atractylenolide I activates the DNA damage-apoptosis axis in colorectal cancer patient-derived organoids by dual-targeting XRCC5 and CLTC. Phytomedicine 149:157564","journal-title":"Phytomedicine"},{"issue":"7","key":"5846_CR3","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","volume":"183","author":"G Ding","year":"2024","unstructured":"Ding G et al (2024) Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr 183(7):3001\u20133011","journal-title":"Eur J Pediatr"},{"key":"5846_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.797499","volume":"13","author":"Z Du","year":"2022","unstructured":"Du Z et al (2022) Atractylenolide I ameliorates acetaminophen-induced acute liver injury via the TLR4\/MAPKs\/NF-kappaB signaling pathways. Front Pharmacol 13:797499","journal-title":"Front Pharmacol"},{"key":"5846_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1476-4598-13-209","volume":"13","author":"JG Fernandez","year":"2014","unstructured":"Fernandez JG et al (2014) Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K\/Akt enhanced beta-catenin\/Tcf-Lef dependent transcription. Mol Cancer 13:209","journal-title":"Mol Cancer"},{"key":"5846_CR6","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1038\/srep03840","volume":"4","author":"JM Huang","year":"2014","unstructured":"Huang JM et al (2014) Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4\/MyD88-dependent pathway. Sci Rep 4:3840","journal-title":"Sci Rep"},{"issue":"2","key":"5846_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.RA118.004638","volume":"294","author":"JS Hwang","year":"2019","unstructured":"Hwang JS et al (2019) Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation. J Biol Chem 294(2):608\u2013622","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"5846_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D et al (2023) BCL-2 protein family: attractive targets for cancer therapy. Apoptosis 28(1\u20132):20\u201338","journal-title":"Apoptosis"},{"issue":"4","key":"5846_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ptr.2040","volume":"21","author":"CQ Li","year":"2007","unstructured":"Li CQ, He LC, Jin JQ (2007) Atractylenolide I and atractylenolide III inhibit Lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother Res 21(4):347\u2013353","journal-title":"Phytother Res"},{"issue":"3","key":"5846_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/15548627.2024.2421699","volume":"21","author":"Q Li","year":"2025","unstructured":"Li Q et al (2025) Atractylenolide I inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1\/HIF2alpha. Autophagy 21(3):619\u2013638","journal-title":"Autophagy"},{"issue":"1","key":"5846_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-016-0845-5","volume":"14","author":"H Liu","year":"2016","unstructured":"Liu H et al (2016) Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2\/TLR4 complex-mediated MyD88\/NF-kappaB signaling in vitro. J Transl Med 14(1):104","journal-title":"J Transl Med"},{"issue":"7","key":"5846_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11427-017-9230-2","volume":"61","author":"H Lyu","year":"2018","unstructured":"Lyu H et al (2018) Epigenetic mechanism of survivin dysregulation in human cancer. Sci China Life Sci 61(7):808\u2013814","journal-title":"Sci China Life Sci"},{"issue":"4","key":"5846_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/femsre\/fuw007","volume":"40","author":"RF Maldonado","year":"2016","unstructured":"Maldonado RF, Sa-Correia I, Valvano MA (2016) Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev 40(4):480\u2013493","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"5846_CR14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","volume":"7","author":"DA McAllister","year":"2019","unstructured":"McAllister DA et al (2019) Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health 7(1):e47\u2013e57","journal-title":"Lancet Glob Health"},{"issue":"3","key":"5846_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00431-023-05366-6","volume":"183","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur PM (2024) Childhood community-acquired pneumonia. Eur J Pediatr 183(3):1129\u20131136","journal-title":"Eur J Pediatr"},{"key":"5846_CR16","doi-asserted-by":"crossref","unstructured":"More S, Choi DK (2017) Neuroprotective role of atractylenolide-I in an in vitro and in vivo model of Parkinson's disease. Nutrients 9(5)","DOI":"10.3390\/nu9050451"},{"key":"5846_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.674340","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y et al (2021) Atractylenolide I inhibits NLRP3 inflammasome activation in colitis-associated colorectal cancer via suppressing Drp1-mediated mitochondrial fission. Front Pharmacol 12:674340","journal-title":"Front Pharmacol"},{"issue":"2","key":"5846_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","volume":"27","author":"VV Senichkin","year":"2020","unstructured":"Senichkin VV et al (2020) Saga of Mcl-1: regulation from transcription to degradation. Cell Death Differ 27(2):405\u2013419","journal-title":"Cell Death Differ"},{"key":"5846_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1181951","volume":"14","author":"K Shi","year":"2023","unstructured":"Shi K et al (2023) Therapeutic effects and mechanism of Atractylodis rhizoma in acute lung injury: investigation based on an integrated approach. Front Pharmacol 14:1181951","journal-title":"Front Pharmacol"},{"issue":"6","key":"5846_CR20","first-page":"618","volume":"104","author":"DK Smith","year":"2021","unstructured":"Smith DK, Kuckel DP, Recidoro AM (2021) Community-acquired pneumonia in children: rapid evidence review. Am Fam Physician 104(6):618\u2013625","journal-title":"Am Fam Physician"},{"issue":"2","key":"5846_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/1078-0432.CCR-22-2088","volume":"29","author":"SI Tantawy","year":"2023","unstructured":"Tantawy SI et al (2023) Mechanisms of MCL-1 protein stability induced by MCL-1 antagonists in B-cell malignancies. Clin Cancer Res 29(2):446\u2013457","journal-title":"Clin Cancer Res"},{"key":"5846_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.18632\/oncotarget.28440","volume":"14","author":"SI Tantawy","year":"2023","unstructured":"Tantawy SI et al (2023) Decoding the mechanism behind MCL-1 inhibitors: a pathway to understanding MCL-1 protein stability. Oncotarget 14:653\u2013655","journal-title":"Oncotarget"},{"issue":"10","key":"5846_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1593\/neo.12598","volume":"14","author":"D Trivigno","year":"2012","unstructured":"Trivigno D et al (2012) Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1. Neoplasia 14(10):893\u2013904","journal-title":"Neoplasia"},{"key":"5846_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13046-016-0312-4","volume":"35","author":"R Yu","year":"2016","unstructured":"Yu R et al (2016) Anti-tumor effects of Atractylenolide I on bladder cancer cells. J Exp Clin Cancer Res 35:40","journal-title":"J Exp Clin Cancer Res"},{"issue":"25","key":"5846_CR25","doi-asserted-by":"publisher","first-page":"14165","DOI":"10.1021\/acs.jafc.3c08188","volume":"72","author":"C Yuan","year":"2024","unstructured":"Yuan C et al (2024) Atractylenolide I alleviates indomethacin-induced gastric ulcers in rats by inhibiting NLRP3 inflammasome activation. J Agric Food Chem 72(25):14165\u201314176","journal-title":"J Agric Food Chem"},{"key":"5846_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejphar.2015.08.022","volume":"765","author":"JL Zhang","year":"2015","unstructured":"Zhang JL, Huang WM, Zeng QY (2015) Atractylenolide I protects mice from lipopolysaccharide-induced acute lung injury. Eur J Pharmacol 765:94\u201399","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5846_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2010.03.165","volume":"395","author":"P Zhao","year":"2010","unstructured":"Zhao P et al (2010) Regulation of survivin by PI3K\/Akt\/p70S6K1 pathway. Biochem Biophys Res Commun 395(2):219\u2013224","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05846-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:16:14Z","timestamp":1787274974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05846-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":27,"alternative-id":["5846"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05846-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study did not involve human participants, patient-derived specimens, identifiable human data, or the prospective collection of human biological materials.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}